OncoCyte Corporation (OCX) Social Stream



OncoCyte Corporation (OCX): $0.21

-0.01 (-3.78%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add OCX to Watchlist
Sign Up

ONCOCYTE CORP (OCX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering OCX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $11 $5 $7.75 $0.214 3521.5%
2021-11-10 3 $11 $7 $8.333 $0.214 3793.93%
2021-12-16 3 $11 $5 $7.666 $0.214 3482.24%
2022-01-06 5 $11 $3.1 $6.525 $0.214 2949.07%
2022-02-01 5 $11 $3.1 $5.84 $0.214 2628.97%
2022-03-17 5 $11 $1.8 $5.225 $0.214 2341.59%
2022-04-01 5 $11 $1.8 $4.95 $0.214 2213.08%
2022-05-16 5 $11 $1.4 $4.85 $0.214 2166.36%
2022-06-06 5 $11 $1.25 $4.662 $0.214 2078.5%
2022-08-11 6 $4 $1.25 $2.35 $0.214 998.13%
2022-08-17 6 $4 $1.25 $2.37 $0.214 1007.48%
2022-09-01 6 $4 $1.15 $2.35 $0.214 998.13%
2022-11-01 5 $4 $0.9 $2.3 $0.214 974.77%
2022-11-11 5 $4 $0.9 $2.16 $0.214 909.35%
2022-11-14 5 $4 $0.9 $2.06 $0.214 862.62%
2022-11-18 5 $4 $0.5 $1.96 $0.214 815.89%
2022-12-07 5 $4 $0.5 $1.46 $0.214 582.24%
2023-04-10 5 $4 $0.4 $1.36 $0.214 535.51%
2023-05-01 4 $4 $0.4 $1.17 $0.214 446.73%
2023-05-14 3 $4 $0.3 $1.287 $0.214 501.4%

The Trend in the Analyst Price Target


OCX's average price target has moved down $6.38 over the prior 17 months.

Over the past 49 weeks, OCX's average upside potential has been 276.68%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-17 6 4 1.25 2.370 0.874 171.17%
2022-11-18 5 4 0.50 1.960 0.440 345.45%
2023-02-02 5 4 0.40 1.360 0.388 250.52%
2023-04-10 5 4 0.40 1.360 0.350 288.57%
2023-05-14 3 4 0.30 1.287 0.252 410.71%

OCX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.67 0 1 2 0 0 3

The Trend in the Broker Recommendations


OCX's average broker recommendation rating worsened by 1.67 over the prior 35 months.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • OCX has a higher average analyst price target than 82.04% of all US stocks.
  • OCX has a greater upside potential (average analyst target price relative to current price) than 2617.58% of all US stocks.
  • ONCOCYTE CORP's variance in analysts' estimates is lower than -2332.24% of stocks in the small market cap category.
  • In the context of Healthcare stocks, ONCOCYTE CORP's number of analysts covering the stock is higher than 695.5% of them.

In the Pharmaceutical Products industry, TRIB, ABIO, and TKNO are the three stocks most similar to ONCOCYTE CORP regarding the price target and analyst recommendation information presented here.

What is the outlook for OCX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.9613 seconds.